Neuro Oncology Articles & Analysis
16 news found
January’s Journal of Neurosurgery (JNS) published a series of 17 videos that examine the application of exoscopic visualization in cerebrovascular, neuro-oncologic, pediatric, peripheral nerve, and spinal neurosurgery. ...
Results from the study were featured in a poster presentation at then 27th Annual Meeting and Education Day of the Society for Neuro-Oncology on November 18, 2022 and available online at Neuro-Oncology Journal Article EPCO-06 It has been a surprise to most oncologists that DNA mismatch repair (MMR) deficiency determines ...
Today, xCures announced that they will present two posters at the 27th Annual Meeting of the Society for Neuro-Oncology, from the 16th to the 20th of November 2022, in Tampa Bay, Florida. The Society for Neuro-Oncology is a multidisciplinary society of healthcare professionals dedicated to promoting advances in ...
ByxCures
Secondary objectives of the study are to evaluate progression-free survival at six months by magnetic resonance imaging, assessment using Response Assessment in Neuro-Oncology criteria, and to evaluate overall survival at 12 months. ...
ByCervoMed
Mark Gilbert and Terri Armstrong of the NIH Neuro-Oncology Branch. August 2017. https://www.cancer.gov/news-events/cancer-currents-blog/2017/glioblastoma-research-making-progress The University of Texas MD Anderson Cancer Center. ...
Manmeet Ahluwalia, M.D., M.B.A., Chief of Medical Oncology, Chief Scientific Officer and Deputy Director at Miami Cancer Institute, part of Baptist Health South Florida, at the 2022 ASCO Annual Meeting June 3-7th during the Central Nervous Systems Tumors Session and available online as Abstract 2053. “The molecular heterogeneity of GBM is a key driver for the inconsistent ...
Gauden served as Product Leader for oncology molecular imaging at GE Healthcare, with business responsibility for the product portfolio, licensing, product development and strategic marketing activities across a range of developmental PET drugs. ...
He was also Co-Director of the Lombardi Neuro-Oncology Division and Co- Director of the CyberKnife Radiosurgery Center, where he was active in advancing stereotactic radiosurgery for treatment of complex spinal tumors. ...
It's the first device of its kind, and its ability to deliver safe and effective Surgically Targeted Radiation Therapy (STaRT) for patients is groundbreaking in the neuro-oncology community." The in-person AANS meeting was cancelled due to Covid-19. ...
In November, INOVIO presented overall survival at 18 months (OS18) data from its novel combination trial of INO-5401 and INO-9012 in combination with PD-1 inhibitor Libtayo® at the Society for Neuro-Oncology (SNO) 2020 Annual Meeting. Median overall survival among the unmethylated Glioblastoma Multiforme (GBM) patients in the trial was 17.9 months, which ...
In addition to the registry trial, two additional studies evaluating GammaTile Therapy in patients with brain metastases were announced at the 2020 Society of Neuro-Oncology Virtual Meeting on Brain Metastases in August. Those studies, which are led by The University of Texas MD Anderson Cancer Center and Memorial Sloan Kettering Cancer Center, are expected to ...
Furthermore, we are very happy that Prof. Timothy Cloughesy, Director of Neuro-Oncology, UCLA, and one of the world’s leading specialists for the treatment of brain tumors, has agreed to head a future US trial with ParvOryx as Principal ...
Vogelbaum, Professor of Neurosurgery at Cleveland Clinic Lerner College of Medicine and Associate Director of Cleveland Clinic’s Rose Ella Burkhardt Brain Tumor and Neuro-Oncology Center. The CMC features four independent delivery microcatheters. ...
“The unmet need and true therapeutic target in glioblastoma is the infiltrating tumor that extends beyond the enhancing tumor,” said Vogelbaum, the associate director of the Brain Tumor and Neuro-Oncology Center at Cleveland Clinic. “The Cleveland Multiport Catheter is designed specifically to deliver therapeutics to regions of brain, not just ...
Dubbed MDA7, the compound reduced neuro-inflammation and stopped the progression of such conditions in animal tests. ...
” The scientists included with their letter a copy of a new scientific study by Santosh Kesari, MD, PhD, chief of neuro-oncology University of California, San Diego, and Anthony B. Miller, MD. former Dean of Public Health, University of Toronto, and expert advisor to the IARC, and Devra Davis PhD, MPH, President of Environmental Health Trust that concludes ...